Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. is dated August 26, 2016. The report incorporates by reference a press release announcing financial results for the six months ended June 30, 2016, along with updates on the company's drug development programs.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached Exhibit 99.1 (Press Release), which is referenced but not included in the source text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. The document serves primarily as a vehicle to incorporate the August 26, 2016 press release into the company's registration statements.
Guidance, Outlook, and Risks
The filing indicates that the incorporated press release contains updates on drug development programs. However, the text of this Form 6-K does not detail specific guidance, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Review the full text of the August 26, 2016 press release (Exhibit 99.1) for specific financial results for the six months ended June 30, 2016.
- Verify the status and milestones of the company's drug development programs as described in the press release.
- Confirm the incorporation of this report into Registration Statements on Form F-3 (File Nos. 333-195124, 333-199033, 333-204795, and 333-209037).